Orphanet: Search by disease/gene
x

Search for a research project

* (*) mandatory field

114 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

WIEN
WIEN

3D 2HG mapping as biomarker for IDH-mutation in glioma
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

UNITED KINGDOM

Greater London
LONDON

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

TERT promoter mutations and cancer aggressiveness
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberBRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für klinische Pharmakologie

AUSTRIA

WIEN
WIEN

Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

FINLAND

Finland
KUOPIO

New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto
A.I.Virtanen -Instituutti

FINLAND

Finland
KUOPIO

Funded by an IRDiRC memberLAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland
Faculty of Health Sciences

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCE

AUVERGNE-RHONE-ALPES
ILLKIRCH

Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
LBP - Laboratory of Bioimaging and Pathologies
Tumoral signaling and therapeutic targets

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Identification of networks of alternative splicing events that coordinate cell heterogeneity and resistance to glioblastoma therapies
Centre de Recherche en Cancérologie Lyon-Est
Diversité du transcriptome des cellules souches

FRANCE

BRETAGNE
RENNES

Tumor activity of IRE1 and remodeling of the immune microenvironment of glioblastomas
Centre de Lutte Contre le Cancer Eugène Marquis
Oncogenesis, Stress & Signaling Laboratory

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Funded by an IRDiRC memberBRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - FR (Partener 1)
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

FRANCE

NORMANDIE
CAEN

Radiosensitization and reoxygenation of tumors via zeolites containing gadolinium: an original theranostic approach for glioblastomas
GIP CYCERON
Equipe CERVOxy | Hypoxie, physiopathologies cérébrovasculaire et tumorale

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
Pharmaxon

GERMANY

Nordrhein-Westfalen
DÜSSELDORF

Targeting HOTAIRM1 in Glioblastoma Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

PORTUGAL

CENTRO
BRAGA

SPAIN

Cantabria
SANTANDER

Funded by an IRDiRC memberContribution of the hypoxia-odz1 axis to the invasive capacity of glioblastoma
IDIVAL: Instituto de Investigación Marqués de Valdecilla
Grupo de Señalización Celular y Dianas Terapéuticas en Cáncer

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberImmunobiology of malignant glioma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberGlioblastoma stem cell-derived pericytes and cancer invasion
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberModeling malignant progression in glioma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberNeuronal activity-regulated mechanisms of glioma growth
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberNeuroimmunology of malignant brain tumors: innate mechanisms
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberRole of glud2 as a metabolic driver of gliomas with idh1 mutations
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberSystemic gene therapy for glioblastoma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberThe mayo gbm xenograft national resource
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberTargeting epha2 in glioblastoma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberSelective targeting of glioma stem cells through sema3c/plexind1
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberUbiquitination and deubiquitination of c-myc in glioblastoma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberChromatin modifications in gbm-propagating cells
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberCellular plasticity and equilibrium in gbm progression
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberExploiting mtap deletion for gbm therapeutics
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberMechanisms of riok2 function in glioblastoma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberThe role of tumor associated macrophages in glioblastoma
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberTargeting kif11 to treat glioblastoma invasion and proliferation
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberPhysical-chemical aspects of cell and tissue excitability
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberTherapeutically relevant targets of twist1 dimers in glioma
Institution: Information not provided - US

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberTargeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

AUSTRIA

WIEN
WIEN

Improved Visualization and Resection of Brain Tumors with Quantitative Fluorescence and Optical Coherence Tomography
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Magnetic Resonance Fingerprinting of Patients with Gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

GERMANY

Nordrhein-Westfalen
BONN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Functional role of genes and pathways in histone H3 mutated gliomas
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

GERMANY

Rheinland-Pfalz
MAINZ

GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients
Universitätsmedizin Mainz
Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

IRELAND

County Dublin
DUBLIN

PORTUGAL

SUL
LISBOA

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

SWEDEN

Region Uppsala
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

SWITZERLAND

Suisse Alémanique
BERN

Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
University Hospital Inselspital
Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANY

Baden-Württemberg
HEIDELBERG

Funded by an IRDiRC memberERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ITALY

VENETO
PADOVA

Funded by an IRDiRC memberModulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Multicentric Research projects